Is the burden of Staphylococcus aureus among patients with surgical site infections growing?

Infection Control and Hospital Epidemiology

Volumn 25, Issue 6, 2004, Pages 457-460

  Jernigan, John A ^a,b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAM ANTIBIOTIC; PSEUDOMONIC ACID; VANCOMYCIN;

DEMOGRAPHY; DISEASE ASSOCIATION; EDITORIAL; ELDERLY CARE; HUMAN; INFECTION; KNEE ARTHROPLASTY; LIFE EXPECTANCY; MORBIDITY; MORTALITY; MULTIVARIATE ANALYSIS; NONHUMAN; STAPHYLOCOCCUS AUREUS; STATISTICAL SIGNIFICANCE; SURGICAL INFECTION;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; CROSS INFECTION; HOSPITALS; HUMANS; INFECTION CONTROL; METHICILLIN RESISTANCE; MIDDLE AGED; MUPIROCIN; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; SURGICAL WOUND INFECTION; UNITED STATES;

EID: 2942595752     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/502421     Document Type: Editorial

References (25)

1. Martone WJ, Jarvis WP, Edwards JR, Culver DH, Haley RW. Incidence and nature of endemic and epidemic nosocomial infections. In: Bennett JV, Brachman PS, eds. Hospital Infections, ed. 4. Philadelphia: Lippincott-Raven; 1998:461-476.
2. National Nosocomial Infections Surveillance System. National Nosocomial Infections Surveillance (NNIS) System report: data summary from October 1986-April 1996, issued May 1996. Am J Infect Control 1996;24:380-388.
3. Petti CA, Sanders LL, Trivette SL, Briggs J, Sexton DJ. Postoperative bacteremia secondary to surgical site infection. Clin Infect Dis 2002;34:305-308.
4. McGarry SA, Engemann JJ, Schmader K, Sexton DJ, Kaye KS. Surgical-site infection due to Staphylococcus aureus among elderly patients: mortality, duration of hospitalization, and cost. Infect Control Hosp Epidemiol 2004;25:461467.
5. Sharma M, Berriel-Cass D, Baran J Jr. Sternal surgical-site infection following coronary artery bypass graft: prevalence, microbiology, and complications during a 42-month period. Infect Control Hosp Epidemiol 2004;25:468471.
6. Harrington G, Russo P, Spelman D, et al. Surgical-site infection rates and risk factor analysis in coronary artery bypass graft surgery. Infect Control Hosp Epidemiol 2004;25:472-476.
7. Minnema B, Vearncombe M, Augustin A, Gollish J, Simor AE. Risk factors for surgical-site infection following primary total knee arthroplasty. Infect Control Hosp Epidemiol 2004;25:477-480.
8. Herwaldt LA, Cullen JJ, French P, et al. Preoperative risk factors for nasal carriage of Staphylococcus aureus. Infect Control Hosp Epidemiol 2004;25:481-484.
9. U.S. Census Bureau. Projected Population of the United States, by Age and Sex: 2000 to 2050. Washington, DC: U.S. Census Bureau. Available at www.census.gov/ipc/www/usinterimproj. Accessed May 10, 2004.
10. Etzioni DA, Liu JH, Maggard MA, Ko CY. The aging population and its impact on the surgery workforce. Ann Surg 2003;238:170-177.
11. Herwaldt LA. Staphylococcus aureus nasal carriage and surgical-site infections. Surgery 2003;134:S2-S9.
12. Cimochowski GE, Harostock MD, Brown R, Bernardi M, Alonzo N, Coyle K. Intranasal mupirocin reduces sternal wound infection after open heart surgery in diabetics and nondiabetics. Ann Thorac Surg 2001;71:1572-1578.
13. Gernaat-van der Sluis AJ, Hoogenboom-Verdegaal AM, Edixhoven PJ, Spies-van Rooijen NH. Prophylactic mupirocin could reduce orthopedic wound infections: 1,044 patients treated with mupirocin compared with 1,260 historical controls. Acta Orthop Scand 1998;69:412414.
14. Kluytmans JA, Mouton JW, VandenBergh MF, et al. Reduction of surgical-site infections in cardiothoracic surgery by elimination of nasal carriage of Staphylococcus aureus. Infect Control Hosp Epidemiol 1996;17:780-785.
15. Perl TM, Cullen JJ, Wenzel RP, et al. Intranasal mupirocin to prevent postoperative Staphylococcus aureus infections. N Engl J Med 2002;346:1871-1877.
16. Kalmeijer MD, Coertjens H, van Nieuwland-Bollen PM, et al. Surgical site infections in orthopedic surgery: the effect of mupirocin nasal ointment in a double-blind, randomized, placebo-controlled study. Clin Infect Dis 2002;35:353-358.
17. Farr BM. Mupirocin to prevent S. aureus infections. N Engl J Med 2002;346:1905-1906.
18. Weber MM, Gordon S, Cwynar R, Banbury M, Lober C, Procop G. Preoperative detection of nasal carriage of staphylococcus aureus and the effect of eradication with intranasal mupirocin on postoperative infections in patients undergoing open heart surgery. Presented at the 14th Annual Meeting of the Society for Healthcare Epidemiology of America; April 17-12, 2004; Philadelphia, PA. Abstract 244:104.
19. Shrestha NK, Shermock KM, Gordon SM, et al. Predictive value and cost-effectiveness analysis of a rapid polymerase chain reaction for preoperative detection of nasal carriage of Staphylococcus aureus. Infect Control Hosp Epidemiol 2003;24:327-333.
20. Boyce JM. Preventing staphylococcal infections by eradicating nasal carriage of Staphylococcus aureus: proceeding with caution. Infect Control Hosp Epidemiol 1996;17:775-779.
21. Engemann JJ, Carmeli Y, Cosgrove SE, et al. Adverse clinical and economic outcomes attributable to methicillin resistance among patients with Staphylococcus aureus surgical site infection. Clin Infect Dis 2003;36:592-598.
22. Cosgrove SE, Sakoulas G, Perencevich EN, Schwaber MJ, Karchmer AW, Carmeli Y. Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clin Infect Dis 2003;36:53-59.
23. Karchmer AW. Staphylococcus aureus and vancomycin: the sequel. Ann Intern Med 1991;115:739-741.
24. Muto CA, Jernigan JA, Ostrowsky BE, et al. SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and Enterococcus. Infect Control Hosp Epidemiol 2003;24:362-386.
25. Manian FA, Meyer PL, Setzer J, Senkel D. Surgical site infections associated with methicillin-resistant Staphylococcus aureus: do postoperative factors play a role? Clin Infect Dis 2003;36:863-868.